FDA: We have APPROVED
… We have approved [ Approval Letter ]
… Whole Blood and blood components
… Convalescent Plasma, High Titer, Anti-SARS-CoV-2 (Whole Blood-derived)
… and Apheresis Convalescent Plasma
… Indication:
Treatment of COVID-19 in patients with immunocompromise-immunosuppressive disease/process
or receiving immunosuppressive treatments
at risk of severe disease progression
in either the inpatient or outpatient setting [ FDA ]